THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 89 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $616,000 | -93.6% | 27,154 | -93.2% | 0.53% | -85.2% |
Q1 2018 | $9,689,000 | -19.7% | 399,537 | -7.6% | 3.59% | -1.1% |
Q4 2017 | $12,063,000 | -18.5% | 432,532 | 0.0% | 3.63% | -21.4% |
Q3 2017 | $14,810,000 | -17.6% | 432,532 | -4.2% | 4.62% | -22.9% |
Q2 2017 | $17,980,000 | +8.2% | 451,306 | 0.0% | 5.99% | +3.7% |
Q1 2017 | $16,617,000 | +2.4% | 451,306 | -11.3% | 5.77% | +17.0% |
Q4 2016 | $16,230,000 | +5.7% | 509,083 | +20.1% | 4.93% | -5.1% |
Q3 2016 | $15,361,000 | +33.0% | 423,881 | -16.7% | 5.20% | +35.3% |
Q2 2016 | $11,547,000 | +20.7% | 508,881 | 0.0% | 3.84% | +40.1% |
Q1 2016 | $9,567,000 | +14.7% | 508,881 | 0.0% | 2.74% | +0.1% |
Q4 2015 | $8,341,000 | +30.0% | 508,881 | -12.8% | 2.74% | +52.2% |
Q3 2015 | $6,417,000 | -15.6% | 583,881 | 0.0% | 1.80% | -14.6% |
Q2 2015 | $7,602,000 | -25.0% | 583,881 | 0.0% | 2.11% | -18.6% |
Q1 2015 | $10,130,000 | -27.3% | 583,881 | -37.5% | 2.59% | -22.3% |
Q4 2014 | $13,934,000 | -29.3% | 933,881 | +9.1% | 3.34% | -38.3% |
Q3 2014 | $19,722,000 | +34.7% | 855,616 | +86.3% | 5.41% | +28.7% |
Q2 2014 | $14,640,000 | – | 459,234 | – | 4.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |